958 days since the first case of coronavirus in the UK.

The ZOE COVID Study’s positive symptomatic case estimate is currently 124,785 cases (+8.6% in a week). The 7-day estimate shows 841,434 cases (+10.3%). On average, it is now estimated that at least 120,205 people* are still infected by coronavirus every day in the UK.

(*this is the equivalent of the population ¹ of the district of Sevenoaks ² in Kent being infected every day.)  

Vaccination remains the best defence against severe disease and hospitalisation. It is also very much sensible to wear a face covering in crowded, enclosed spaces.

🙈🙉🙊 #CovidIsNotOver

First published in Sept 2022.

covid summary

Latest UK Dashboard

Our reporting strategy

Since 27 July we don’t publish the UKHSA data in our daily reporting. Those figures are just conveniently and undoubtedly flawed. Instead, we now focus on the ZOE COVID Study and the ONS Infection Survey data.

Our readers deserve the truth about COVID-19 and the UK government has clearly been doing everything – from ending free tests to irregular dashboard reports, delaying and ending some data reports – to make sure the media slowly lose interest in COVID reporting and get the public to believe both that they can live with the virus and that the pandemic is over. This is wrong and untrue, as the WHO and most public health experts have repeatedly told us.

For these reasons, PMP Magazine has so far, and will continue to publish COVID daily updates because we see it as part of our mission to always report the truth, even if it means we are the last media in the UK to do so.

While others are sleepwalking to hide the inconvenient truth about COVID-19, PMP Magazine isn’t giving up! Our daily report is free and accessible to all.

Please support our work with a donation: PMP-Magazine.com/crowdfunding

COVID is not over.

Reminder on data reporting in the UK

Since 1 July 2022, the COVID-19 UKHSA Dashboard has moved to weekly reporting. From 8 September 2022, updates take place on Thursdays.
The reporting of ZOE COVID Study data has remained daily.
The reporting of ONS Infection Survey data has remained weekly with a 7-day lag.

(Source: UKHSA | ZOE | ONS)

Zoe COVID Study Estimates

■ Daily Estimated Cases

After having plateaued for a couple of weeks, we have seen an increase in symptomatic cases for 16 consecutive days now. How prepared are we for the autumn and winter waves? Shouldn’t booster jabs be available to everyone as soon as possible?

ONS Infection Survey Estimates

■ Weekly Estimates Cases

The percentage of people testing positive for coronavirus continued to decrease in England and Wales in the latest week (ending 28 August 2022). The trend was uncertain in Northern Ireland and Scotland.

The ONS estimates that 944,700 people tested positive for COVID-19 in that week.

■ Weekly COVID-19 Recorded Deaths

Deaths involving COVID-19 increased in the UK
According to the ONS, there were 350 deaths registered in the UK involving coronavirus in the week ending 2 September 2022, down from 505 in the previous week.

The total number of UK deaths was 10,198, which was 7.4% above the five-year average (706 excess deaths). This means COVID-19 deaths accounted for 3.4% of all deaths in the latest week, a decrease from 4.1% in the previous week.

(The number of death registrations in the week ending 2 September 2022 are affected by the bank holiday on 29 August 2022. Caution is needed when comparing across weeks, and with the five-year average.)

latest guidance

UK Government’s List of symptoms of COVID-19

After two years without updating its list of just three symptoms of COVID-19 (a high temperature, a new continuous cough and a loss or change to the sense of smell or taste), the NHS has finally updated its list of symptoms of COVID:

😩 Shortness of breath
🥱 Feeling tired or exhausted
🤕 An aching body
🤯 A headache
🤐 A sore throat
🤧 A blocked or runny nose
😞 Loss of appetite
🥴 Diarrhoea
🤮 Feeling sick or being sick

No change to MHRA advice on the safety and effectiveness of COVID-19 vaccines for those who are pregnant or breastfeeding

Our advice remains that the COVID-19 vaccines are safe and effective during pregnancy and breastfeeding.

We are aware of false claims on social media that our advice on the safety and effectiveness of COVID-19 vaccines while pregnant or breastfeeding has changed.

We would like to reassure the public that our advice has not changed. Our advice remains that the COVID-19 vaccines are safe and effective during pregnancy and breastfeeding and there is substantial evidence to support this advice.

(Source: MHRA, Medicines and Healthcare products Regulatory Agency)

TRAVEL: Entry rules and restrictions

Check out the latest situation for 20 of the top travel destinations for Brits:

ZOE COVID Study’s Top 20 symptoms of COVID-19 (as of 8-Sep-2022)

latest news

End of global Covid-19 pandemic in sight — WHO chiefs

In a press conference, Dr Tedros Adhanom Ghebreyesus, the World Health Organization’s Director-General, said:

“Last week, the number of weekly reported deaths from COVID-19 (globally) was the lowest since March 2020.

“We have never been in a better position to end the pandemic. We are not there yet, but the end is in sight.

“A marathon runner does not stop when the finish line comes into view, she runs harder, with all the energy she has left. So must we.

“We can see the finish line, we are in a winning position, but now is the worst time to stop running. Now is the time to run harder, and make sure we cross the line and reap the rewards of all our hard work.

“You should still plan for surges of cases, and make sure you have the supplies, equipment and health workers you will need.

“Since New Year’s Eve in 2019, and every day since then, WHO has worked without rest to warn the world, and to give people everywhere the tools they need to stay safe, save lives, and keep societies functioning.

“We have helped countries to build oxygen plants and treatment centres. We have shipped millions of masks, gowns, tests, vaccines and more to countries that need them, all over the world.

“We have advised governments on how to find the right mix of public health measures, and with our partners in Covax, we have delivered more than 1.7bn doses of vaccine around the world. Low-income countries have relied on us for three-quarters of their vaccine doses.”

Dr Maria Van Kerkhove, Infectious Disease Epidemiologist and COVID-19 Technical Lead, said:

“We expect there to be future waves of infection, potentially at different time points throughout the world, caused by different sub-variants of Omicron or different variants of concern, but those future waves of infection do not need to translate into future waves of death, because we have tools that can prevent infections, can prevent transmissions – critically the use of vaccines, early use of anti-virals can prevent people from developing severe disease and dying.”

Infections continued to decrease in England and Wales — ONS

The percentage of people testing positive for coronavirus continued to decrease in England and Wales, with the trend being uncertain in Scotland and Northern Ireland in the latest week (ending 28 August 2022 for England, Wales and Scotland and ending 26 August 2022 for Northern Ireland).

The estimated percentage of the population living in private households (those not in care homes or other communal establishments) testing positive for COVID-19 in the latest week was:

  • 1 in 70 people
  • 1 in 95 people
  • 1 in 50 people
  • 1 in 50 people

Infections decreased in most age groups in England in the latest week, except in those aged school Year 12 to age 24 years and those aged 70 years and over, where the trend was uncertain. Infections decreased in most English regions, except the East Midlands, East of England and South East where trends were uncertain, in the latest week.

(Source: ONS)

For more stories like this,
sign up to our FREE Briefings today.

covid tweets

we need your help

Since February 2022, the UKHSA has slowly reduced the publishing of its daily COVID updates, following the UK Government’s narrative that we should all “live with the virus”. UKHSA now reports only once a week.

The virus doesn’t take a break 6 days a week.
It doesn’t infect people from time to time.
It doesn’t stop at a border either.

The virus still spreads and kills people every day in the UK and around the world. COVID-19 is NOT over.

We, at PMP, have decided to continue to publish the latest COVID data available every day, especially the Zoe COVID Study estimates – probably more accurate than the UK Government’s own data since free testing has ended in England,  and the ONS COVID Infection Survey estimates.

Please, support our work through our crowdfunding to help us to continue our COVID reporting: Donate now.

🙈🙉🙊 #CovidIsNotOver.


These are the groups of people eligible for the autumn Covid-19 booster vaccine
The UK became the first country in the world to approve Moderna’s bivalent vaccine which is part of the autumn booster programme.
WHO calls for action as 17 million long Covid cases estimated in Europe | Nursing Times
Governments and health authorities across Europe have been urged to improve the reporting and treatment of long Covid, after new analysis suggested at
Israel to roll out adapted COVID booster this month, official says
Israel will offer the updated COVID-19 booster shots from Pfizer (PFE.N)/BioNTech (22UAy.DE) designed to combat the Omicron BA.4/5 subvariants by the end of September, a senior health official said on Wednesday.


variant news

■ 🧬 UKHSA Variant Technical Briefing


BA.5 is the predominant circulating variant in the UK.


Analysis of the relative risk of admission to hospital as an inpatient following presentation to emergency care, comparing BA.4 and BA.5 to BA.2 found no evidence for a difference in risk between the variants.


Newly designated variant – V-22SEP-01 (BA.4.6) Omicron sub-lineage BA.4.6 was identified as part of horizon scanning on 15 August 2022. On 1 September 2022 BA.4.6 was designated as variant V-22SEP-01.

BA.4.6 has a mutation in a known antigenically significant site (S: R346T) and an apparent small growth advantage relative to BA.5. BA.4.6 represented 3.31% of UK samples for the week beginning 14 August 2022. The University of Oxford reported preliminary neutralisation data to the Variant Technical Group. Pseudoviral neutralisation assays performed on BA.4.6 show that titres are reduced 2-fold, compared to neutralisation of BA.4 or BA.5 using sera from triple dosed recipients of the Pfizer BNT162b2 vaccine.


As of 6 September 2022, there were 100 cases with BA.2.75 in the UK. Of these, 89 were in England, 7 in Scotland and 4 in Wales. BA.2.75 is currently increasing in frequency in England. The growth rate increased from July 2022 to August 2022 and is currently 61% per week compared to co-circulating lineages.

Two sub-lineages of BA.2.75 (BA.2.75.1 and BA.2.75.2) are currently being assessed. Sublineage BA.2.75.1 is defined by the addition of S:D574V, and sub-lineage BA.2.75.2 by the addition of S:R346T, S:F486S, S:D1199N. Sub-lineage BA.2.75.2 was first identified as part of horizon scanning on 20 August 2022 and was made a signal in monitoring on 7 September 2022.

(Source: UKHSA)

■ 🧬 COG-UK sequencing

(Source: COG-UK)


💉 Latest UK Vaccination

Note: UK vaccination data is now published weekly on Thursdays.

(Source: UK Health Security Agency + Public Health Wales
+ Public Health Scotland + HSC NI + ONS)

Note: Data cross-referenced with the latest official data from the UK dashboard.

PMP Xtra

Total UK population: 67,081,234 (last year: 66,796,800), via ONS (subject to changes in population over the year). These figures were updated on 25 June 2021. (Source: ONS)

long covid

🧩 Long COVID

LONG COVID UK ESTIMATE (ONS – 1-Sep-2022, Data up to 31-Jul-2022)

🚨 2 million people currently live with long COVID in the UK (vs 1.8 million last month)
🚨 3.1% of the UK population currently live with long COVID (vs 2.8%)
🚨 1 in 33 people in the UK has long COVID
🚨 Long COVID symptoms still adversely affect the day-to-day activities of 1.5 million people, 73% of long COVID sufferers (vs 1.3 million)
🚨 Of those, 384,000 people (19%) are “limited a lot” (vs 369,000)
🚨 582,000 (29%) first had COVID-19 before Alpha became the main variant; 256,000 (13%) in the Alpha period, 386,000 (19%) in the Delta period, and 681,000 (34%) in the Omicron period.

🚨 Most common symptoms of long COVID
▫ fatigue (62%) ▲
▫ shortness of breath (37%) ▲
▫ difficulty concentrating (33%) ▲
▫ muscle ache (31%) ▲

🚨 Prevalence of long COVID is greatest in people
▫ aged 35-69 years
▫ females
▫ living in more deprived areas
▫ working in social care
▫ with another activity limiting health condition or disability

🚨 Long COVID by occupation (ONS – 29 Jun-2022)
▫ Police and protective services (25%)
▫ Education (22%)
▫ Social care sector (22%)

Note: There has been a change in the way the data are collected by the ONS. As a result, these estimates are not fully comparable with those in previous bulletins. For more details on these changes, please see the Impact of moving to remote data collection.

long covid kids

🧩 Long COVID Kids


According to a recent systematic review and meta-analyses of Long-COVID in children and adolescents published in Nature:

🚨 Long COVID affects 1 in 4 infected children (25.24%)

🚨 For hospitalised children, prevalence of long-COVID is nearly 1 in 3 infected children (29.19%)

🚨 Most prevalent clinical manifestations of Long COVID in children/adolescents:
▫ mood symptoms (16.50%)
▫ fatigue (9.66%)
▫ sleep disorders (8.42%)
▫ headache (7.84%)
▫ respiratory symptoms (7.62%)
▫ sputum production or nasal congestion (7.53%)
▫ cognitive symptoms (6.27%)
▫ loss of appetite (6.07%)
▫ exercise intolerance (5.73%)
▫ altered smell (5.60%)

🚨 Children infected by COVID-19 have a higher risk of persistent dyspnea, anosmia/ageusia, and/or fever

🚨 Like adults, the pediatric population’s risk factors associated with long-COVID are:
▫ older age children
▫ female gender
▫ severe COVID-19
▫ overweight/obesity
▫ comorbid allergic diseases and other long-term co-morbidities

Click to enlarge


The authors of the systematic review and meta-analyses of Long-COVID in children and adolescents conclude:

Protective measures are essential to prevent long-COVID in children. We need to understand the long-COVID pathophysiology and symptomatology to support clinical management systems, establish rehabilitation programs, and design guidelines and therapeutic research.
Long-COVID represents a significant public health concern, and there are no guidelines to address its diagnosis and management.
“Our meta-analyses further support the importance of continuously monitoring the impact of long-COVID in children and adolescents and the need to include all variables and appropriate control cohorts in studies to better understand the real burden of pediatric long-COVID.”

additional data

Weekly New Hospital Admissions for COVID-19 (per million)

Total Cases & Total Deaths

Orphanhood in the UK

🕯️ Orphanhood of children from COVID-19 is estimated at 15,189 in the UK.
🚨 A tragedy barely mentioned in the media.
(Source: Imperial College London)

Orphanhood in the World

🕯️ Globally 10.5M children lost parents or caregivers and 7.5M children experienced COVID-associated orphanhood.
(Source: JAMA Network)

Estimated ®️ Number

(Sources: UK Health Security Agency + Welsh Government
+ Scottish Government + N-I Ministry of Health)

Population Testing Positive for COVID-19

(Source: ONS)

Number of contact tracing alerts sent (England & Wales)

(Source: NHS)

Stringency Index

(Source: University of Oxford)

data sources

📚 Data Sources:

PMP Magazine

Going further:

  • Estimates of the population for the UK, England and Wales, Scotland and Northern Ireland, 2019 | ONS
  • Sevenoaks District, Kent

  • — AUTHOR —

    J.N. PAQUET, Author & Journalist, Editor of PMP Magazine.

    • Text: This piece was first published in PMP Magazine on 14 Sept 2022. | The authors write in a personal capacity.
    • Data cross-referenced with the latest official data from the UK dashboard.
    • Cover: Adobe Stock/SergeyBitos.
    • Icons from www.flaticon.com

    [Read our Comments Guidelines]